Analysts note the growing risks around U.S. President Donald Trump’s ability to maintain a fragile trade truce.
Analysts say that after a roughly two-year turnaround the company’s retail pharmacy business and other units may be strong enough to stand on their own.
The Investing Club holds its “Morning Meeting” every weekday at 10:20 a.m. ET.
This post was originally published on this site.Trump is a frequent critic of media companies, especially broadcasters that he views as being biased against him.
The move would reverse the company’s $78 billion acquisition of Aetna, and dismantle the vertically integrated healthcare conglomerate it created in 2018.
Novo raises full-year outlook as Wegovy pill sales impress
Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates
Treasury yields fall as investors crowd into bonds for safety amid election stock sell-off
Treasury yields fell on Tuesday night, as investors sought shelter from a sell-off in equity futures sparked by big victories from Democrats in the U.S….
This post was originally published on this site.Tuesday’s midterm elections follow record spending on AI-generated political ads.
Disney plans several thousand layoffs, asks some managers to cut costs by up to 20%
This post was originally published on this site.Disney expects to lay off several thousand employees in the latest round of job cuts for the entertainment…
Pfizer hikes full-year outlook, taps company veteran as new CFO
Pfizer announced that Cecile Guegan, who has held various leadership roles at the company over the last 20 years, stepped in as CFO this month.
Versant earnings beat expectations as digital platforms drive growth
This post was originally published on this site.Versant posted third-quarter earnings that beat Wall Street expectations and reaffirmed its full-year guidance.
Versant earnings beat expectations as digital platforms drive growth
This post was originally published on this site.Versant posted third-quarter earnings that beat Wall Street expectations and reaffirmed its full-year guidance.





